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Abstract
Background
Skin fibrosis is a significant medical problem that leads to a functional, aesthetic, and psy-
chosocial impact on quality-of-life. Light-emitting diode-generated 633-nm red light (LED-
RL) is part of the visible light spectrum that is not known to cause DNA damage and is con-
sidered a safe, non-invasive, inexpensive, and portable potential alternative to ultraviolet
phototherapy that may change the treatment paradigm of fibrotic skin disease.
Objective
The goal of our study was to investigate the how reactive oxygen species (ROS) free radi-
cals generated by high fluence LED-RL inhibit the migration of skin fibroblasts, the main cell
type involved in skin fibrosis. Fibroblast migration speed is increased in skin fibrosis, and
we studied cellular migration speed of cultured human skin fibroblasts as a surrogate mea-
sure of high fluence LED-RL effect on fibroblast function. To ascertain the inhibitory role of
LED-RL generated ROS on migration speed, we hypothesized that resveratrol, a potent
antioxidant, could prevent the photoinhibitory effects of high fluence LED-RL on fibroblast
migration speed.
Methods
High fluence LED-RL generated ROS were measured by flow cytometry analysis using
dihydrorhodamine (DHR). For purposes of comparison, we assessed the effects of ROS
generated by hydrogen peroxide (H2O2) on fibroblast migration speed and the ability of res-
veratrol, a well known antioxidant, to prevent LED-RL and H2O2 generated ROS-associated
changes in fibroblast migration speed. To determine whether resveratrol could prevent the
PLOSONE | DOI:10.1371/journal.pone.0140628 October 21, 2015 1 / 9
OPEN ACCESS
Citation: Mamalis A, Koo E, Isseroff RR, Murphy W,
Jagdeo J (2015) Resveratrol Prevents High Fluence
Red Light-Emitting Diode Reactive Oxygen Species-
Mediated Photoinhibition of Human Skin Fibroblast
Migration. PLoS ONE 10(10): e0140628. doi:10.1371/
journal.pone.0140628
Editor: Michael Hamblin, Massachusetts General
Hospital, UNITED STATES
Received: July 14, 2015
Accepted: September 29, 2015
Published: October 21, 2015
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: All relevant data are
available on figshare at the following DOIs: 10.6084/
m9.figshare.1545633; 10.6084/m9.figshare.1545634;
10.6084/m9.figshare.1545635.
Funding: This study was funded using Institutional
Startup Funds from Dr. Jared Jagdeo and by the
National Center for Advancing Translational
Sciences, National Institutes of Health, through grant
number UL1 TR000002 and linked awards TL1
TR000133 and KL2 TR000134.
high fluence LED-RL ROS-mediated photoinhibition of human skin fibroblast migration,
treated cells were incubated with resveratrol at concentrations of 0.0001% and 0.001% for
24 hours, irradiated with high fluences LED-RL of 480, 640, and 800 J/cm2.
Results
High fluence LED-RL increases intracellular fibroblast ROS and decreases fibroblast migra-
tion speed. LED-RL at 480, 640 and 800 J/cm2 increased ROS levels to 132.8%, 151.0%,
and 158.4% relative to matched controls, respectively. These LED-RL associated increases
in ROS were prevented by pretreating cells with 0.0001% or 0.001% resveratrol. Next, we
quantified the effect of hydrogen peroxide (H2O2)-associated ROS on fibroblast migration
speed, and found that while H2O2–associated ROS significantly decreased relative fibro-
blast migration speed, pretreatment with 0.0001% or 0.001% resveratrol significantly pre-
vented the decreases in migration speed. Furthermore, we found that LED-RL at 480, 640
and 800 J/cm2 decreased fibroblast migration speed to 83.0%, 74.4%, and 68.6% relative
to matched controls, respectively. We hypothesized that these decreases in fibroblast
migration speed were due to associated increases in ROS generation. Pretreatment with
0.0001% and 0.001% resveratrol prevented the LED-RL associated decreases in migration
speed.
Conclusion
High fluence LED-RL increases ROS and is associated with decreased fibroblast migration
speed. We provide mechanistic support that the decreased migration speed associated
with high fluence LED-RL is mediated by ROS, by demonstrating that resveratrol prevents
high fluence LED-RL associated migration speed change. These data lend support to an
increasing scientific body of evidence that high fluence LED-RL has anti-fibrotic properties.
We hypothesize that our findings may result in a greater understanding of the fundamental
mechanisms underlying visible light interaction with skin and we anticipate clinicians and
other researchers may utilize these pathways for patient benefit.
Introduction
Skin fibrosis is a significant medical problem that has a functional, aesthetic, and psychosocial
impact on a patient’s quality-of-life.[1] Skin fibrosis results from altered cellular pathways initi-
ated by chronic injury or inflammation. The unifying characteristics of skin fibrosis are
increased fibroblast proliferation, collagen production, and transforming growth factor beta
(TGF-Beta) signaling.[2] Skin fibrosis-derived fibroblasts also demonstrate increased migra-
tion speed compared to fibroblasts derived from normal human skin.[3,4] Unfortunately, there
are few effective therapies for skin fibrosis and further research in this area is needed.
Ultraviolet (UV) phototherapy is currently used to treat some fibrotic skin diseases, how-
ever, UV light is associated with DNA damage leading to skin cancer and premature aging.
[5,6] In contrast, light-emitting diode-generated 633-nm red light (LED-RL) is part of the visi-
ble spectrum that is not known to cause DNA damage and is considered a safe, non-invasive,
inexpensive, and portable potential alternative to ultraviolet phototherapy that may change the
treatment paradigm of fibrotic skin disease.[7–11] However, LED-RL’s molecular effects and
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underlying mechanisms are not well characterized. Low fluence LED-RL is associated with
stimulatory effects such as wound healing and hair regrowth.[12] On the other hand, inhibitory
effects are observed at higher fluences. For example, early clinical observations have demon-
strated the anti-fibrotic effects of high fluence LED-RL, although the mechanisms underpin-
ning this inhibition have remained largely unexplored.[13] The molecular effects of LED-RL
are hypothesized to be modulated by mitochondrial cytochrome C oxidase.[14] The photoinhi-
bitory effects of high fluence LED-RL lead to downstream modulation of key cellular processes
involved in skin fibrosis.[11]
Resveratrol, a natural molecule derived from fresh grape skin, red wine, and Japanese knot-
weed, has significant antioxidant properities.[15,16] Research demonstrates that resveratrol is
a potent antioxidant in human skin fibroblasts in vitro, and also modulates a number of key
cellular pathways related to skin fibrosis including the TGF-beta/SMAD pathway, collagen
deposition, and cellular proliferation.[17–20] These biologic effects in fibroblasts are hypothe-
sized to be due to antioxidant capabilities, however, resveratrol can also cause direct effects on
cellular pathways through other less-characterized mechanisms.[21] This makes resveratrol a
good candidate for exploring the LED-RL photobiomodulatory effects on human skin
fibroblasts.
The goal of our study was to investigate the mechanism by which reactive oxygen species
(ROS) free radicals generated by high fluence LED-RL inhibit migration in skin fibroblasts.
Fibroblast migration speed is increased in skin fibrosis, and we studied cellular migration
speed in cultured human skin fibroblast model as a surrogate measure of high fluence LED-RL
effect on fibroblast function. To ascertain the inhibitory role of ROS on migration speed, we
hypothesized that resveratrol, a potent antioxidant scavenger of ROS, could prevent the photo-
inhibitory effects of high fluence LED-RL on fibroblast migration speed.
Methods
Cell Culture of Skin Fibroblasts
Monolayers of commercially available patient-derived primary human skin fibroblasts
(AG13145, Coriell Institute) were cultured as previously described.[9] Fibroblasts were seeded
in 35-mm tissue culture dishes at a density of 2x104 cells per tissue culture dish. To demon-
strate that resveratrol could modulate the effects of LED-RL, treated plates were incubated with
resveratrol (Sigma-Aldrich, St. Louis, MO. USA) dissolved in DMEM at concentrations of
0.0001% and 0.001% for 24 hours prior to irradiation. Resveratrol concentrations studied were
selected based upon previous demonstration of resveratrol’s antioxidant properties in human
skin fibroblasts by our group.[16]
High Fluence LED-RL Irradiation of Skin Fibroblasts
Fibroblasts were irradiated 24 hours after plating, using a 633-nm LED-RL array (Omnilux
New-U, Photo Therapeutics, Carlsbad, CA) at a power density of 872.6 W/m2 and fluences of
480, 640, and 800 J/cm2 (1:31:41, 02:02:14, and 2:32:47 hr:min:sec, respectively) at room tem-
perature. Each experimental plate receiving LED-RL treatment was compared with a tempera-
ture matched control plate to ensure that the measured effect was a result of LED treatment
and not due to ambient light or environment. Controls were derived from the same stock of
trypsinized cell suspension and plated to adhere in the same manner as the experimental con-
ditions, taken out of the incubator at the same time as their matched treatment pairs, protected
from the LED light source, and placed on a digital warming blocking with a negative feedback
temperature control system set at 32°C. In all groups, medium temperatures throughout irradi-
ation remained 32–34°C as measured using a digital thermometer (HH506RA, Omega
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Engineering, Stamford, CT). By remaining within physiologic temperature range, heat stress
was not induced. LED-RL fluences were selected based upon previously published studies that
demonstrated LED photoinhibition of skin fibroblast proliferation.[7,9,10]
Hydrogen Peroxide Treatment of Skin Fibroblasts
Fibroblasts were treated with 1.2 mM hydrogen peroxide (H2O2, Sigma-Aldrich) 24 hours after
plating for a duration of 30 minutes. Following treatment with H2O2, cells were washed with
PBS and fresh medium was added. Concentration and duration of H2O2 exposure was selected
based upon previous antioxidant studies by our group.[16,22,23]
Flow-Cytometry Based Quantification of High Fluence LED-RL
Generated Reactive Oxygen Species using Dihydrorhodamine
Intracellular ROS generation in fibroblasts was assessed as previously described.[16] Briefly,
2x104 cells were plated per dish, intravitally stained with DHR, and then irradiated as described
above. Following irradiation, cells were washed with PBS, collected with trypsin, and processed
for flow cytometry analysis. The level of intracellular ROS was evaluated by flow cytometry
analysis using a Guava easyCyte HT system at 525 nm. Mean fluorescent intensity was mea-
sured for each group and statistical analysis of data was performed using the paired two-tailed
Student’s t -test, with significance level set at p< 0.05. In ROS experiments, the sample size
was n = 3 for each experimental condition. Experiments were repeated twice to ensure
reproducibility.
Time-Lapse Video Single Cell Migration Microscopy
Time-lapse video migration experiments were performed as described with modifications on a
Nikon TE-2000 microscope with a motorized stage.[24] For migration experiments, cultured
human fibroblast cells were plated on 35 mm2 culture dishes with CO2-independent medium
(Invitrogen) and incubated for 24 hours. In some experimental conditions, human fibroblasts
were pretreated with resveratrol as described above. Cells were irradiated or treated with H2O2
as described above. Following irradiation, time-lapse images were captured every 30 minutes
for 4 hours in an environmental chamber monitored under microscopy with the temperature
maintained at 37°C. The time-lapse videos were generated using Volocity Image Software (Per-
kinElmer) and were analyzed using Openlab Software (PerkinElmer) to measure cell migration
speed. “Migration speed” is the average speed in μm per minute that the cells travel in a 4-hour
period. Statistical analysis of data was performed using the paired two-tailed Student’s t-test,
significance level was set at p< 0.05. For each group, at least 40 cells were tracked to quantify
migration speed and experiments were repeated twice to ensure reproducibility.
Statistical Analysis
Statistical analyses with Student’s t-test was performed using GraphPad Prism version 6.00 for
OSX (GraphPad Software, San Diego, CA, USA) to compare individual treatment arms and
matched controls. The significance level was set at p< 0.05. Experimental design and sample
size was chosen based upon guidance by a biostatistician.
Results
High fluence LED-RL increased intracellular fibroblast ROS. LED-RL at fluences of 480, 640,
and 800 J/cm2 significantly increased ROS levels in a dose-dependent manner as measured by
DHR (Fig 1A and 1B). These increases in ROS were prevented by pretreating cells with
High Fluence Red Light-Emitting Diode Reactive Oxygen Photoinhibition
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0.0001% or 0.001% resveratrol. ROS levels are presented as median fluorescent intensity of
DHR of treated cells relative to matched controls. ROS generation of 480, 640, and 800 J/cm2
LED-RL was 132.8±2.5% (p = 0.0006), 151.0±5.2% (p = 0.0001), 158.4±1.3% (p = 0.0018),
respectively, compared to 100.0±2.2% in control. Pretreatment with 0.0001% resveratrol signif-
icantly reduced ROS generation of 480, 640, and 800 J/cm2 LED-RL to 127.6±1.3 (p = 0.0005),
132.8±2.1 (p = 0.0048), and 131.2±5.1 (p = 0.0002), respectively (p-values compared to
matched LED-RL group that was not treated with resveratrol). Pretreatment with 0.001% res-
veratrol significantly reduced ROS generation of 480, 640, and 800 J/cm2 LED-RL to 107.5±1.4
(p = 2.3E-05), 116.2±1.7 (p = 0.0002), and 117.8±1.9 (p = 9.6E-07) (p-values compared to
matched LED-RL group that was not treated with resveratrol).
We next assessed the effects of ROS generated by 1.2 mMH2O2 on fibroblast migration
speed and the ability of 0.0001% and 0.001% resveratrol to prevent ROS-associated changes in
fibroblast migration speed. Pretreatment of fibroblasts with 1.2 mMH2O2 for 30 minutes sig-
nificantly decreased relative fibroblast migration speed to 63.5±4.2% (p = 4.28–07) compared
to matched controls (100±5.3%) (Fig 2). Pretreatment with 0.0001% resveratrol prevented the
effects of H2O2 (1.2 mM) compared to LED-RL alone and resulted in a relative migration
speed of 80.6±5.5% (p = 0.024). Pretreatment with 0.001% resveratrol significantly prevented
the effects of H2O2 (1.2 mM) compared to LED-RL alone and resulted in a relative migration
speed of 94.5±4.7% (p = 0.001).
High fluence LED-RL decreased fibroblast cell migration speed. LED-RL at a fluence of 480
J/cm2 significantly decreased relative fibroblast migration speed to 83.0±5.6% (p = 0.0393)
compared to matched control (100±5.8%) (Fig 3A). Pretreatment with 0.0001% and 0.001%
resveratrol prevented LED-RL (480 J/cm2) effects compared to LED-RL alone and resulted in
Fig 1. Light-emitting diode generated red light (LED-RL) at a fluences of 480, 640, and 800 J/cm2 significantly increased reactive oxygen species
asmeasured by DHR. These increases in ROS were significantly prevented by pretreating cells with 0.0001% or 0.001% resveratrol. (A) Representative
flow cytometry analysis of untreated and resveratrol pretreated fibroblasts stained with dihydrorhodamine. Red curves represent cells treated with LED-RL at
the labeled fluence. Blue curves represent matched controls. (B) ROS levels are presented as median fluorescent intensity of DHR of treated cells relative to
matched controls. ROS generation of 480, 640, and 800 J/cm2 LED-RL was 132.8±2.5% (p = 0.0006), 151.0±5.2% (p = 0.0001), 158.4±1.3% (p = 0.00184),
respectively, compared to 100.0±2.2% in control. Pretreatment with 0.0001% resveratrol significantly reduced ROS generation of 480, 640, and 800 J/cm2
LED-RL to 127.6±1.3 (p = 0.000483), 132.8±2.1 (p = 0.00481), and 131.2±5.1 (p = 0.00022), respectively (p-values compared to matched LED-RL group that
was not treated with resveratrol). Pretreatment with 0.001% resveratrol significantly reduced ROS generation of 480, 640, and 800 J/cm2 LED-RL to 107.5
±1.4 (p = 2.3E-05), 116.2±1.7 (p = 0.00018), and 117.8±1.9 (p = 9.6E-07) (p-values compared to matched LED-RL group that was not treated with
resveratrol). Error bars represent standard error of the mean. (* represents P < .05).
doi:10.1371/journal.pone.0140628.g001
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relative migration speeds of 88.1±3.5% (p = 0.4837) and 103.7±5.0% (p = 0.0623), respectively.
LED-RL at a fluence of 640 J/cm2 significantly decreased relative fibroblast migration speed to
74.4±5.5% (p = 0.0003) compared to matched control (100±4.2%) (Fig 3B). Pretreatment with
0.0001% and 0.001% resveratrol prevented LED-RL (640 J/cm2) effects compared to LED-RL
alone and resulted in relative migration speeds of 82.0±4.1% (p = 0.3068) and 99.0±5.3%
(p = 0.0009), respectively. LED-RL at a fluence of 800 J/cm2 significantly decreased relative
fibroblast migration speed to 68.6±4.5% (p = 0.0003) compared to matched control (100
±4.2%) (Fig 3C). Pretreatment with 0.0001% or 0.001% resveratrol significantly prevented
LED-RL’s (800 J/cm2) effects compared to LED-RL alone and resulted in relative migration
speeds of 83.0±3.9% (p = 0.019) and 101.9±4.2% (p = 0.0006), respectively.
Fig 2. Pretreatment of fibroblasts with 1.2 mMH2O2 for 30 minutes significantly decreased relative fibroblast migration speed to 63.5±4.2%
(p = 4.28–07) compared to matched controls (100±5.3%). Pretreatment with 0.0001% resveratrol significantly prevented the effects of H2O2 (1.2 mM)
compared to LED-RL alone and resulted in a relative migration speed of 80.6±5.5% (p = 0.024). Pretreatment with 0.001% resveratrol significantly prevented
the effects of H2O2 (1.2 mM) compared to LED-RL alone and resulted in a relative migration speed of 94.5±4.7% (p = 0.001). Error bars represent standard
error of the mean. (* represents P < .05).
doi:10.1371/journal.pone.0140628.g002
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Discussion
High fluence LED-RL decreases skin fibroblast migration speed. Mechanistically, the high flu-
ence LED-RL decrease in migration speed is associated with a dose-dependent increase in
intracellular ROS. We previously have demonstrated that resveratrol has antioxidant properties
in skin fibroblasts. To investigate the role of high fluence LED-RL mediated ROS, we used res-
veratrol at previously studied doses that demonstrated antioxidant effects to confirm that pre-
vention of intracellular ROS generated by LED-RL prevented the concomitant inhibition of
migration.
Our study results demonstrate that LED-RL at fluences of 480, 640, and 800 J/cm2 increase
ROS in a dose dependent manner and decrease fibroblast migration speed. These LED-RL
associated increases in ROS were prevented by pretreating cells with resveratrol. We next dem-
onstrated that H2O2-associated ROS inhibition of fibroblast migration speed could be reversed
by resveratrol. Furthermore, we found that LED-RL at 480, 640 and 800 J/cm2 decreased fibro-
blast migration speed. We hypothesized that these dose-dependent decreases in fibroblast
migration speed were due to increases in ROS generation and used hydrogen peroxide to con-
firm the role of increased ROS in decreased migration speed. Pretreatment with 0.0001% res-
veratrol partially prevented the LED-RL associated decrease in migration speed, while
pretreatment with 0.001% resveratrol completely prevented the LED-RL associated decreases
in migration speed.
To our knowledge, this is the first report that resveratrol is capable of preventing the effects
of high-fluence visible red light on human skin fibroblast ROS generation and migration speed.
Previous research indicates that fibroblast migration speed may play a key role in the pathogen-
esis of skin fibrosis and may underlie one of the underappreciated therapeutic challenges asso-
ciated with skin fibrosis.[3,4] Our findings are important as they provide a mechanistic
understanding of how high fluence LED-RL may induce photoinhibitory effects on human
Fig 3. Light-emitting diode generated red light (LED-RL) at a fluence of 480 J/cm2 significantly decreased relative fibroblast migration speed to
83.0±5.6% (p = 0.0393) compared to matched controls (100±5.8%). A. Pretreatment with 0.0001% resveratrol partially prevented LED-RL’s (480 J/cm2)
effects compared to LED-RL alone and resulted in a relative migration speed of 88.1±3.5% (p = 0.4837). Pretreatment with 0.001% resveratrol partially
prevented LED-RL’s (480 J/cm2) effects compared to LED-RL alone and resulted in a relative migration speed of 103.7±5.0% (p = 0.0623). Error bars
represent standard error of the mean. (* represents P < .05). Fig 3B. Light-emitting diode generated red light (LED-RL) at a fluence of 640 J/cm2 significantly
decreased relative fibroblast migration speed to 74.4±5.5% (p = 0.0003) compared to matched controls (100±4.2%). Pretreatment with 0.0001% resveratrol
partially prevented LED-RL’s (640 J/cm2) effects compared to LED-RL alone and resulted in a relative migration speed of 82.0±4.1% (p = 0.3068).
Pretreatment with 0.001% resveratrol significantly prevented LED-RL’s (640 J/cm2) effects compared to LED-RL alone and resulted in a relative migration
speed of 99.0±5.3% (p = 0.0009). Error bars represent standard error of the mean. (* represents P < .05). Fig 3C. Light-emitting diode generated red light
(LED-RL) at a fluence of 800 J/cm2 significantly decreased relative fibroblast migration speed to 68.6±4.5% (p = 0.0003) compared to matched controls (100
±4.2%). Pretreatment with 0.0001% resveratrol significantly prevented LED-RL’s (800 J/cm2) effects compared to LED-RL alone and resulted in a relative
migration speed of 83.0±3.9% (p = 0.019). Pretreatment with 0.001% resveratrol significantly prevented LED-RL’s (800 J/cm2) effects compared to LED-RL
alone and resulted in a relative migration speed of 101.9±4.2% (p = 0.0006). Error bars represent standard error of the mean. (* represents P < .05).
doi:10.1371/journal.pone.0140628.g003
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skin fibroblasts via increases in ROS generation. Elucidating the mechanisms that underlie visi-
ble light phototherapy could assist in optimizing anti-fibrotic LED-RL phototherapy settings
and may provide the basis for development of additional antifibrotic adjunctive therapies. Fur-
thermore, understanding these LED-RL associated mechanisms is important as it may reveal
potential therapeutic targets for treating conditions associated with pathologic fibroblast states
that clinically feature skin fibrosis.
A limitation of this study is that we used cultured human skin fibroblasts. Cultured fibro-
blasts do not completely recapitulate the complex physiologic state of fibroblasts that are con-
tributing to pathologic states leading to skin fibrosis in vivo. However, use of cultured cells may
also be considered a strength of this study since we used fibroblasts available from a commer-
cial cell repository. Therefore, these results can be repeated and confirmed by other investiga-
tors. Another limitation of our study is the inability to ascribe resveratrol effects on fibroblast
migration speed and ROS production as purely a function its antioxidant properties, as resvera-
trol may function through other cellular pathways. We believe our use of commercially avail-
able LEDs as a visible light source is a strength of our study as other researchers may utilize
these arrays for photobiomodulation research.[7,25]
Conclusion
High fluence LED-RL increases ROS and is associated with decreased fibroblast migration
speed. We provide mechanistic support that decreased migration speed is associated with high
fluence LED-RL generated ROS through the use of resveratrol to prevent high fluence LED-RL
associated migration speed change. These data lend support to an increasing scientific body of
evidence that high fluence LED-RL has anti-fibrotic properties. We hypothesize our findings
may result in a greater understanding of the fundamental mechanisms underlying visible light
interaction with skin and we anticipate clinicians and other researchers may utilize these path-
ways for patient benefit.
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